Indeed, our data provide new evidence that, beyond its well known anti-tumor effects, IL-27 may also elicit immune-regulatory circuits, particularly in the tumor environment, through the induction of PD-L1 and/or IDO in EOC cells and monocytes. The gene discussed is IL27; the disease is neoplasm.